Pharmaceutical giant Sanofi becomes latest to cap US insulin prices. Liberal-news

US President Joe Biden, who has led calls for lower costs of the drug, said in a statement on Thursday: “As of this afternoon, the top three insulin producers in the United States have agreed to reduce their prices substantially, following my calls to expand my $35 senior limit to all Americans.”

Leave a comment

Your email address will not be published. Required fields are marked *